Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

EPRXEPRX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in EUPRAXIA PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 58,058 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $383,763 as of 2026-Q2. The position was increased (+9.4% shares).

Current Value

$383,763

Current Shares

58,058

Total Value Change

+$274,398

Total Shares Change

+23,558

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
58,058
+9.4%
$383,7630.0%$6.61
18
2026-Q1
Decreased
53,080
-8.6%
$384,2990.0%$8.02
0
2025-Q4
Increased
58,058
+44.8%
$438,3380.0%$7.59
32
2025-Q3
Increased
40,100
+0.8%
$236,5900.0%$5.75
16
2025-Q2
Increased
39,800
+15.4%
$229,2480.0%$5.30
18
2025-Q1
Unchanged
34,500
0.0%
$113,1600.0%$3.38
0
2024-Q4
New
34,500
-
$109,3650.0%$3.09
33

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used